Jinko Raises €2 Million to Enhance Post-Cancer Care Solutions

Jinko, an innovative startup focused on enhancing the quality of life for individuals affected by cancer, has successfully raised €2 million in an initial funding round. This significant investment was led by 360 Capital, with notable participation from AFI Ventures—Ventech's impact arm—and ten business angels from diverse sectors including medicine, entrepreneurship, insurance, and pharmaceuticals.

With this new funding, Jinko aims to accelerate its growth and expand its reach. The primary objectives include broadening partnerships within the healthcare ecosystem, increasing visibility among patients and healthcare professionals, and enhancing the functionality of its digital application. This funding round marks a crucial step in Jinko's journey to transform supportive care for cancer patients.

Jinko’s core mission is to provide personalized supportive care designed to improve the overall experience of cancer patients during their treatment and recovery phases. By offering a holistic and multidisciplinary approach, Jinko addresses a wide range of needs through various forms of supportive care, including dietary counseling, psychological support, adapted physical activities, socio-aesthetics, and osteopathy. These services are delivered by a network of certified and compassionate practitioners, ensuring that each patient receives tailored care.

Research underscores the significant role of supportive care in the treatment of cancer. More than 80% of cancer patients experience physical or psychological effects related to their cancer or its treatment. Studies show that supportive care can effectively reduce mortality rates, decrease the recurrence of cancer, minimize side effects, and enhance the effectiveness of primary treatments. In fact, three out of four French individuals view supportive care as being as critical as the treatments themselves.

Dr. Rémy Salmon, a cancer surgeon, commends Jinko for its initiative in this area. He notes that doctors often require additional support in providing comprehensive care, and Jinko’s approach to understanding and addressing patients' needs at the right time with appropriate interventions is a valuable addition to the current healthcare landscape.

Jinko’s care journey begins with a consultation with a nurse who evaluates the patient's specific needs to craft a personalized care plan. This plan includes weekly care sessions, which can be conducted either in-person or via video call. Additionally, patients receive ongoing advice and micro-exercises tailored to their condition through a dedicated app developed by Jinko. The nurse remains the primary point of contact throughout the process, ensuring continuous and personalized support.

The integration of digital technology is a key component of Jinko’s service. The company has developed its own platform to facilitate seamless coordination among nurses, patients, and practitioners. This platform allows patients to access their care plans and exercises instantly, enhancing the overall efficiency and effectiveness of the care provided. A patient testimonial highlights the positive impact of Jinko’s services: "A personalized care journey with experienced and compassionate professionals enabled me to return to work with confidence. I highly recommend Jinko! It’s a wonderful experience."

Recognizing the often high costs associated with supportive care, Jinko is working towards offering reduced rates for its services. The startup has an ambitious long-term goal of making these services entirely free for all individuals affected by cancer. This commitment reflects Jinko’s dedication to removing financial barriers to accessing necessary care and ensuring that every patient can benefit from high-quality supportive services.

Faustine, co-founder of Jinko, emphasizes the startup’s goals: “Our objective is to support 1,000 patients in the next 12 months and continue innovating to provide high-quality care throughout and beyond cancer treatment.” The pilot phase of Jinko’s program has already demonstrated a 38% average improvement in quality of life after three months of care. Looking ahead, Jinko plans to deliver more than 50,000 care sessions over the next three years.

The support from investors highlights the confidence in Jinko’s approach and potential. Clara Cornu and Alexandre Mordacq from 360 Capital express their enthusiasm: “We are delighted to support the talented Jinko team in their first fundraising round. The issue of supportive care is still under-addressed today, and we are convinced that the company’s approach will benefit many.”

Mamadou Dembele, Senior Associate at AFI Ventures, comments on Jinko’s unique position in the market: “We were impressed by Faustine and Anthony’s vision for addressing a market with limited digital solutions. Their holistic approach, integrating technology with a range of human support services, convinces us that it’s the right strategy for this underserved sector.”

As Jinko moves forward, the startup’s focus on integrating technology with personalized care positions it well to address an important and growing need in the healthcare sector. By continuing to refine its services and expand its reach, Jinko aims to make a significant impact on the lives of cancer patients. The support from investors and the positive feedback from patients highlight the promising future for Jinko and its mission to improve the quality of life for those affected by cancer.